BP drug not tied to death risk among heart patientsApril 11th, 2012 - 2:59 pm ICT by IANS
Copenhagen, April 11 (IANS) Losartan, prescribed for lowering high blood pressure (BP), may not be linked with higher death risk in heart failure patients, says a new study.
Henrik Svanstrom of Statens Serum Institut, Copenhagen, Denmark, and colleagues conducted a study to assess whether losartan is tied with increased mortality in heart failure patients as compared with candesartan, the journal JAMA reports.
Candesartan like losartan is a class of drugs called angiotensin II receptor blockers. By blocking the effects of angiotensin II, candesartan causes blood vessels to relax, which can lower BP.
Patients aged 45 years and older with first-time hospitalisation for heart failure in 1998-2008 were identified. The final study group included 6,479 patients; 2,082 users of candesartan and 4,397 users of losartan, according to a Statens statement.
Researchers found no significantly increased risk of death linked with losartan use as compared to candesartan. Also, use of losartan was not significantly tied with an increased risk of cardiovascular mortality compared with candesartan use.
“This large, nationwide cohort study of patients with heart failure found no significantly increased risk of all-cause mortality associated with use of losartan as compared with candesartan,” the researchers conclude.
- BP drug could harm stroke patients - Feb 13, 2011
- Drug used to treat type 2 diabetes linked to heart problems - Mar 18, 2011
- Three-pill combo for high BP launched - Nov 22, 2011
- Following cancer prevention guidelines lower risk of death from all-causes - Apr 16, 2011
- Poor health literacy linked to higher heart failure mortality - Apr 27, 2011
- High resting heart rate may shorten life - Oct 27, 2010
- Device boosts libido of men with heart failure - Jun 02, 2011
- Anti-hypertensive drug improves multiple sclerosis-related brain inflammation - Jul 29, 2010
- Sleeping pills cause higher death risk - Feb 28, 2012
- Combination ACE inhibitor therapy raises risk of kidney failure, death - Mar 22, 2011
- Patients receiving dialysis 'at higher risk for sudden cardiac death' - Nov 15, 2010
- Painkillers shoot up death risk in heart attacks - May 10, 2011
- Blood pressure medications show higher cancer risk: Study - Jun 14, 2010
- Blood pressure drug a boon for stroke patients - Oct 23, 2011
- Hormone therapy ups death risk for prostate cancer patients with heart disease - Aug 26, 2009
Tags: 45 years, blood vessels, candesartan, cardiovascular mortality, cause mortality, cohort study, copenhagen denmark, death risk, heart failure, heart failure patients, heart patients, high blood pressure, hospitalisation, journal jama, losartan, lowering high blood pressure, patients with heart failure, receptor blockers, statens serum institut, study group